514 related articles for article (PubMed ID: 25813876)
1. Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1/S6K1 signaling.
Gao S; Duan C; Gao G; Wang X; Yang H
Int J Biochem Cell Biol; 2015 Jul; 64():25-33. PubMed ID: 25813876
[TBL] [Abstract][Full Text] [Related]
2. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
3. Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle.
Hsieh CT; Chuang JH; Yang WC; Yin Y; Lin Y
Cell Signal; 2014 Jul; 26(7):1400-8. PubMed ID: 24650522
[TBL] [Abstract][Full Text] [Related]
4. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
Khamzina L; Veilleux A; Bergeron S; Marette A
Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
[TBL] [Abstract][Full Text] [Related]
5. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
6. Alpha-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex.
Yang W; Wang X; Duan C; Lu L; Yang H
Neurochem Int; 2013 Sep; 63(3):180-94. PubMed ID: 23796501
[TBL] [Abstract][Full Text] [Related]
7. Fisetin regulates obesity by targeting mTORC1 signaling.
Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
[TBL] [Abstract][Full Text] [Related]
8. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
[TBL] [Abstract][Full Text] [Related]
9. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
Adochio R; Leitner JW; Hedlund R; Draznin B
Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
[TBL] [Abstract][Full Text] [Related]
10. Serine 302 Phosphorylation of Mouse Insulin Receptor Substrate 1 (IRS1) Is Dispensable for Normal Insulin Signaling and Feedback Regulation by Hepatic S6 Kinase.
Copps KD; Hançer NJ; Qiu W; White MF
J Biol Chem; 2016 Apr; 291(16):8602-17. PubMed ID: 26846849
[TBL] [Abstract][Full Text] [Related]
11. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
12. mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8.
Kim SJ; DeStefano MA; Oh WJ; Wu CC; Vega-Cotto NM; Finlan M; Liu D; Su B; Jacinto E
Mol Cell; 2012 Dec; 48(6):875-87. PubMed ID: 23142081
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
[TBL] [Abstract][Full Text] [Related]
14. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells.
Fang CX; Yang X; Sreejayan N; Ren J
Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100
[TBL] [Abstract][Full Text] [Related]
15. Central insulin signaling is attenuated by long-term insulin exposure via insulin receptor substrate-1 serine phosphorylation, proteasomal degradation, and lysosomal insulin receptor degradation.
Mayer CM; Belsham DD
Endocrinology; 2010 Jan; 151(1):75-84. PubMed ID: 19887566
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma and retinoic acid X receptor alpha represses the TGFbeta1 gene via PTEN-mediated p70 ribosomal S6 kinase-1 inhibition: role for Zf9 dephosphorylation.
Lee SJ; Yang EK; Kim SG
Mol Pharmacol; 2006 Jul; 70(1):415-25. PubMed ID: 16611854
[TBL] [Abstract][Full Text] [Related]
17. A positive role of mammalian Tip41-like protein, TIPRL, in the amino-acid dependent mTORC1-signaling pathway through interaction with PP2A.
Nakashima A; Tanimura-Ito K; Oshiro N; Eguchi S; Miyamoto T; Momonami A; Kamada S; Yonezawa K; Kikkawa U
FEBS Lett; 2013 Sep; 587(18):2924-9. PubMed ID: 23892082
[TBL] [Abstract][Full Text] [Related]
18. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling.
Julien LA; Carriere A; Moreau J; Roux PP
Mol Cell Biol; 2010 Feb; 30(4):908-21. PubMed ID: 19995915
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
20. S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.
Lee JE; Lim MS; Park JH; Park CH; Koh HC
Mol Neurobiol; 2016 Aug; 53(6):3771-3782. PubMed ID: 26143260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]